Concepedia

David T Yeung

DT

Statistics

Publications

5

Citations

109

H-Index

5

Active since

1977

Affiliations

Centre for Cancer Biology(Current)

South Australia Pathology

The University of Adelaide

South Australian Health and Medical Research Institute

David T Yeung is an author at Centre for Cancer Biology specializing in health sciences, vascular biology, and hepcidin.

ORCID

Top concepts

Publications per year

1977–2015

5

Publications

5

KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy

David T Yeung, Carine Tang, Ljiljana Vidovic et al. · Blood · 2015 · 30 citations · Full text

Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects

Kate Vandyke, Stephen Fitter, Jenny Drew et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 28 citations

Transferrin and iron uptake by rabbit reticulocytes

Teck Chwen Loh, Y.G. Yeung, David T Yeung · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1977 · 23 citations

, , +13

Any BCR-ABL Reduction Below 10% At 6 Months Of Therapy Significantly Improves Outcome For CML Patients With a Poor Response At 3 Months

Nicola D. Roberts, David T Yeung, FRCPA et al. · Blood · 2013 · 15 citations

Selective Escalation of Imatinib Therapy and Early Switching to Nilotinib In De Novo Chronic Phase CML Patients: Interim Results From the TIDEL-II Trial

David T Yeung, Michael Osborn, Deborah L. White et al. · Blood · 2010 · 13 citations

1–5 of 5